Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.09.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 27.09.2024 | 740 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 27.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 27.09.2024ISIN NameAT0000A18XM4 AMS-OSRAM... ► Artikel lesen | |
DUEARITY Aktie jetzt für 0€ handeln | |||||
10.09.24 | Nasdaq Stockholm AB: Delisting of Duearity AB (publ) from Nasdaq First North Growth Market | 361 | GlobeNewswire | Today, on September 10, 2024, Duearity AB (publ) was declared bankrupt by Malmö
District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the
exchange may decide to... ► Artikel lesen | |
09.09.24 | XFRA 9DS: AUSSETZUNG/SUSPENSION | 268 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDUEARITY AB 9DS... ► Artikel lesen | |
03.09.24 | Nasdaq Stockholm AB: New equity warrant for trading, Duearity AB TO3 | 369 | GlobeNewswire | At the request of Duearity AB, Duearity AB equity warrant will be traded on
First North Growth Market as from September 4, 2024.
Security name: Duearity AB TO3
-------------------------------
Short... ► Artikel lesen | |
03.09.24 | Nasdaq Stockholm AB: New equity right for trading, Duearity AB TO2 | 375 | GlobeNewswire | At the request of Duearity AB, Duearity AB equity rights will be traded on
First North Growth Market as from September 4, 2024.
Security name: Duearity AB TO2
-------------------------------
Short... ► Artikel lesen | |
19.07.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 19.07.2024 | 694 | Xetra Newsboard | Das Instrument D7GA US64026Q1085 NEL ASA ADR/30 NK -,20 EQUITY wird cum Kapitalmassnahme gehandelt am 19.07.2024 und ex Kapitalmassnahme am 22.07.2024 The instrument D7GA US64026Q1085 NEL ASA ADR/30... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 58,18 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
CAPSOVISION | 3,500 | 0,00 % | CapsoVision Prices IPO Of 5.50 Mln Shares At $5.00/shr | WASHINGTON (dpa-AFX) - CapsoVision Inc. (CV), a commercial-stage medical technology company that develops
advanced imaging and artificial intelligence technologies that are deployed in its... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 47,760 | -1,16 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 22,010 | 0,00 % | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | ||
ALIGNMENT HEALTHCARE | 13,610 | -4,22 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
CARL ZEISS MEDITEC | 54,70 | -3,36 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
FRESENIUS | 42,400 | +0,28 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Fresenius auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
MIMEDX | 6,230 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2025 Operating and Financial Results | Net Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05, Respectively First Quarter Adjusted EBITDA... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,250 | -0,36 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
PHETON | 18,380 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
NUTEX HEALTH | 122,29 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
GENEDX | 89,79 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts | ||
ONCOLOGY INSTITUTE | 2,440 | 0,00 % | The Oncology Institute wird exklusiver Anbieter für Nevada Medicaid | ||
908 DEVICES | 6,605 | 0,00 % | 908 Devices Inc.: Romanian Customs Authority Adopts 908 Devices' MX908 for Border Security Operations | The handheld mass spectrometers are now in active use for trace detection and identification of drugs and explosives for customs and border patrol applications 908 Devices Inc. (Nasdaq: MASS)... ► Artikel lesen | |
GOODRX | 5,055 | +1,92 % | GoodRx (GDRX) Unveils Lifecycle to Enhance Engineering Methodologies |